A great many stockholders have looked upon this w

A great many stockholders have looked upon this week as a tragedy for the stock, but in reality it hasn't been that bad and it appears the worst is behind us (at least IMO).

Last Fri closed at .46, triple what it was the previous Fri close.

Now it sits at just about .39, down .07 for the week or about 15% from the .046 close last Fri.

Now who wouldn't say down 15% for a big consolidation week isn't bad at all? The only reason it appears way down (or at least feels way down) was many tried to sell the idea too hard that grant news would come out this week (again, retail, we are our own worst enemy) and some entity seems to have played us early in the week with big run ups Mon and Tues in the last 30 min of the trading day.

All in all, not nearly as dire as some have tried to paint the week and we are now a week closer to getting the grant news. Will it come this week, no one knows, but the chances are much higher every day.

Great update on the IPIX website today and it sure looks like Brilacidin is loaded for bear in handling future tests for CV19 and the other PAN-CORONA viruses.

I think we all look at the profits we missed out on by not trading correctly this week, but in the long run who really wants to chance that many shares flippping when monster news should be right around the corner? I don't trade because I ALWAYS get bitten in the a**. Take away that factor and the week wasn't bad at all.

Brilacidin sure seems to be in the right place at the right time with the right people soon to be doing a full investigative test on its broad spectrum of features and advantages and has a great chance of becoming the super drug it was designed to be. Kevetrin not looking bad, either.